Cardiff Oncology
CARDIFF ONCOLOGY INC Logo
About CARDIFF ONCOLOGY INC
Cardiff Oncology Inc is a clinical-stage biotechnology company focused on developing novel therapies for cancer patients. Leveraging PLK1 inhibition, the company is advancing its lead asset, onvansertib, in combination with standard-of-care therapeutics to address solid tumor and hematologic cancers. Cardiff Oncology's development strategy targets tumor vulnerabilities to overcome treatment resistance and aims to deliver improved clinical outcomes for patients with high unmet medical needs.
Year founded
2009
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
